Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3269183 | HPB | 2013 | 8 Pages |
Abstract
Oxaliplatin treatment was associated with portal vein dilatation. Patients with SI showed a tendency towards decreased mean portal flow velocity. This may indicate that SI is associated with an increased resistance to blood flow in the liver parenchyma. Portal vein haemodynamic variables estimated by MRIF can identify patients without SI nonâinvasively.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Jozef Urdzik, Tomas Bjerner, Alkwin Wanders, Frans Duraj, Ulf Haglund, Agneta Norén,